BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

BD FACSLyric™ Flow Cytometer System with BD Multitest™ Assays Offers Reliability and Consistency Jul 19, 2017 FRANKLIN LAKES, N.J., July 19, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyric™... Read more

New Thermo Scientific Samco Leakproof Vials Offer Enhanced Sample and User Safety

Samco Clicktainer vials provide secure and reliable sample collection and transport Thermo Scientific Sterilin containers suitable for molecular biology and genomic and forensic applications WALTHAM, Mass., July 11, 2017 /PRNewswire/ — For the rigorous requirements of molecular biology, genomic and forensic research facilities, new universal containers are specifically lot tested and certified to be free from RNase, DNase,... Read more

Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research

Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven Fluidigm® microfluidic technology.... Read more

Thermo Fisher Scientific Introduces Next Generation of Complementary Technologies for Forensic DNA Analysis

 Precision ID GlobalFiler NGS STR Panel v2 and Converge 2.0 software enable retrieval of more data from mixed and degraded samples CARLSBAD, Calif., July 18, 2017 /PRNewswire/ — Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to a new next-generation sequencing (NGS)... Read more

Sphere Fluidics Limited and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System

CAMBRIDGE, England, July 17, 2017 /PRNewswire/ — Sphere Fluidics Limited and their partners have just won a $1.25 million grant to develop a novel automated single cell genome engineering platform. The grant syndicate also includes Horizon Discovery (UK), Twist Bioscience (US) and the University of Edinburgh (UK). The grant was an Open Innovation Grant from InnovateUK with participation open to companies in... Read more

Neogen names new CEO

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., July 17, 2017 — Neogen Corporation (NASDAQ: NEOG) announced today the company has named John Adent as chief executive officer, effective immediately. James Herbert, the company’s founder and former CEO, will remain as executive chairman and work closely with Adent in the transition of responsibilities. “I’m... Read more

Canopy Biosciences Enters Bioprocessing Market with Launch of Host Cell Protein Detection Kits

Canopy Biosciences signs deal with Array Bridge to market kits for impurity analysis ST. LOUIS, July 13, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it will enter the bioprocessing field by marketing kits for host cell protein detection. Array Bridge, a biotech company that developed the... Read more

Hitachi High-Technologies Launches HM1000 screening equipment for phthalates

(PDF format, 107kBytes) July 13, 2017 – Quick, simple testing for phthalates newly restricted under RoHS directive – Tokyo, Japan, July 13, 2017 – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that its wholly owned subsidiary and analytical instrument manufacturer and marketer Hitachi High-Tech Science Corporation (“HHT Science”) has developed the HM1000 thermal... Read more

BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa™: First Approved Cell and Gene Therapy for Osteoarthritis

Korean Approval Received by Kolon Life Science, TissueGene’s Exclusive Licensee BOTHELL, Wash., July 13, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), the leading supplier of pre-formulated, clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), today announced that Kolon Life Science, TissueGene’s exclusive licensee for Asia, including Korea, has received marketing approval for Invossa-K Inj., the world’s first cell and... Read more

Teledyne to Acquire Scientific Systems, Inc.

THOUSAND OAKS, Calif. – July 13, 2017 – Teledyne Technologies Incorporated (NYSE:TDY) announced today that its subsidiary, Teledyne Instruments, Inc., has entered into an agreement to acquire assets of Scientific Systems, Inc. (SSI). Headquartered in State College, Pa., SSI manufactures precision components and specialized subassemblies used primarily in analytical and diagnostic instrumentation, such as High... Read more